Giovanni Morani

Author PubWeight™ 2.34^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.	Europace	2015	1.45
2	Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.	Europace	2013	0.90
3	The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.	Europace	2016	0.75
4	Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study.	J Telemed Telecare	2015	0.75